Ultima-Cialis

ULTIMA-CIALIS BY ULTIMA PHARMACEUTICALS

Tablets

DRUG COMPOSITION

1 tablet contains:
 - active substance: tadalafil citrate 25 mg;
 - auxiliary substances:

DRUG DESCRIPTION

PHARMACEUTICAL FORM

Tablets.

PHARMACEUTICAL GROUP AND ATC CODE

PDE5 Inhibitor.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: 17.5 Hours
Routes of administration: by mouth
Dosage forms: (Men): 10-20 mg/day; (Women): -
Acne: no
Water retention: no
High blood pressure: perhaps
Hepatotoxicity: no
Aromatase: no
Decreased HPTA function (own testosterone production): none
Anabolic activity: Not a steroid
Androgenic activity: Not a steroid
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

25 mg tablets.
50 tablets in sachets.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Ultima Pharmaceuticals
Europe